Website review parexel.com
CRO & Biopharmaceutical Services | Parexel
Generated on March 07 2026 21:15 PM
Old data? UPDATE !
The score is 60/100
SEO Content
Title
CRO & Biopharmaceutical Services | Parexel
Length : 42
Perfect, your title contains between 10 and 70 characters.
Description
For over 35 years Parexel has been a trusted global CRO and biopharmaceutical services company. Learn more about how we can help.
Length : 129
Great, your meta description contains between 70 and 160 characters.
Keywords
biopharmaceutical services
Good, your page contains meta keywords.
Og Meta Properties
This page does not take advantage of Og Properties. This tags allows social crawler's better structurize your page. Use this free og properties generator to create them.
Headings
| H1 | H2 | H3 | H4 | H5 | H6 |
| 1 | 2 | 51 | 8 | 32 | 0 |
- [H1] Who we are,
- [H2] While running a triathlon, Andrea stumbled and realized something was wrong.
- [H2] Parexel is proudly among the world’s largest clinical research organizations
- [H3] Solutions
- [H3] Portfolio management and asset valuation
- [H3] Early development and innovation
- [H3] Integrated clinical development
- [H3] Approval and access
- [H3] Value substantiation lifecycle management
- [H3] Operational excellence
- [H3] Biotech
- [H3] Therapeutic Expertise
- [H3] General medicine
- [H3] Infectious disease and vaccines
- [H3] Immunology
- [H3] Oncology
- [H3] Neuroscience
- [H3] Hematology
- [H3] Insights
- [H3] Participate
- [H3] Patient volunteers
- [H3] Sites
- [H3] About
- [H3] Leadership team
- [H3] Compliance, tax & privacy
- [H3] Solutions
- [H3] Portfolio management and asset valuation
- [H3] Early development and innovation
- [H3] Integrated clinical development
- [H3] Approval and access
- [H3] Value substantiation lifecycle management
- [H3] Operational excellence
- [H3] Biotech
- [H3] Therapeutic Expertise
- [H3] General medicine
- [H3] Infectious disease and vaccines
- [H3] Immunology
- [H3] Oncology
- [H3] Neuroscience
- [H3] Hematology
- [H3] Insights
- [H3] Participate
- [H3] Patient volunteers
- [H3] Sites
- [H3] About
- [H3] Leadership team
- [H3] Compliance, tax & privacy
- [H3] She thought it was just an injury. Her hamstrings were tight, and her body felt stiff and slow.
- [H3] She had ALS, a condition affecting more than 200,000 people around the world.
- [H3] Her life expectancy was shortened to just two to five years — but she was determined to make the most of it.
- [H3] Andrea continued to join triathlons, even as she underwent treatment in a clinical trial, inspiring many and raising $1,000,000 for ALS research.
- [H3] Today, alive beyond her original prognosis, she serves on our Patient Advisory Council, using her experiences to help improve our neuroscience trials.
- [H3] Lives can change when you design neuroscience trials with speed and precision.
- [H3] We focus on patients, because they inspire us to deliver better trials, faster than ever. So we can make a difference for more patients everywhere.
- [H4]
- [H4] Oncology
- [H4] I&I
- [H4] Cell & Gene Therapy
- [H4] Endocrine & Metabolic
- [H4] Resources
- [H4] Regional Websites
- [H4] Quick Links
- [H5] WHAT WE DO
- [H5] HOW WE DO IT
- [H5] PODCAST
- [H5] THERAPEUTIC EXPERTISE
- [H5] CROSS-THERAPEUTIC EXPERTISE
- [H5] RELATED INSIGHTS
- [H5] NEW MEDICINES, NOVEL INSIGHTS
- [H5] FEATURED INSIGHTS
- [H5] RECENT INSIGHTS
- [H5]
- [H5] Biopharm workforce report
- [H5] Powered by people
- [H5] INTERESTED IN PARTICIPATING?
- [H5] TRIAL SITES
- [H5] HEAR FROM REAL PATIENTS
- [H5] AWARD-WINNING-PARTNERS
- [H5] WHAT WE DO
- [H5] HOW WE DO IT
- [H5] PODCAST
- [H5] THERAPEUTIC EXPERTISE
- [H5] CROSS-THERAPEUTIC EXPERTISE
- [H5] RELATED INSIGHTS
- [H5] NEW MEDICINES, NOVEL INSIGHTS
- [H5] FEATURED INSIGHTS
- [H5] RECENT INSIGHTS
- [H5]
- [H5] Biopharm workforce report
- [H5] Powered by people
- [H5] INTERESTED IN PARTICIPATING?
- [H5] TRIAL SITES
- [H5] HEAR FROM REAL PATIENTS
- [H5] AWARD-WINNING-PARTNERS
Images
We found 23 images on this web page.
Good, most or all of your images have alt attributes.
Text/HTML Ratio
Ratio : 24%
Good, this page's ratio of text to HTML code is higher than 15, but lower than 25 percent.
Flash
Perfect, no Flash content has been detected on this page.
Iframe
Too Bad, you have Iframes on the web pages, this mean that content in an Iframe cannot be indexed.
SEO Links
URL Rewrite
Good. Your links looks friendly!
Underscores in the URLs
Perfect! No underscores detected in your URLs.
In-page links
We found a total of 162 links including 0 link(s) to files
| Anchor | Type | Juice |
|---|---|---|
| Solutions | Internal | Passing Juice |
| Portfolio management and asset valuation | Internal | Passing Juice |
| Early development and innovation | Internal | Passing Juice |
| Integrated clinical development | Internal | Passing Juice |
| Approval and access | Internal | Passing Juice |
| Value substantiation lifecycle management | Internal | Passing Juice |
| Delivery models | Internal | Passing Juice |
| Operational excellence | Internal | Passing Juice |
| Medical affairs | Internal | Passing Juice |
| Study start-up | Internal | Passing Juice |
| Overview | Internal | Passing Juice |
| Building patient insights into assets, profile and claims | Internal | Passing Juice |
| Portfolio optimization | Internal | Passing Juice |
| Asset valuation and indication prioritization | Internal | Passing Juice |
| Early evidence review | Internal | Passing Juice |
| Integrated development strategy and planning | Internal | Passing Juice |
| Phase I Clinical Trials | Internal | Passing Juice |
| Site Alliance Network and KOL Engagement | Internal | Passing Juice |
| Quantitative Clinical Pharmacology and Model-Informed Drug Development (MIDD) | Internal | Passing Juice |
| Regulatory Strategy | Internal | Passing Juice |
| Real World Evidence | Internal | Passing Juice |
| Market Access Consulting, Strategy, and Delivery | Internal | Passing Juice |
| Biomarker and Genomic Medicine Strategy | Internal | Passing Juice |
| Integrated evidence generation planning | Internal | Passing Juice |
| Medical Communications | Internal | Passing Juice |
| Phase IIB-IV Clinical Trials | Internal | Passing Juice |
| Real World Evidence | Internal | Passing Juice |
| Quantitative Clinical Pharmacology and Model-Informed Drug Development (MIDD) | Internal | Passing Juice |
| Protocol-Driven, Customized Site Solution Strategy | Internal | Passing Juice |
| Patient Inclusion | Internal | Passing Juice |
| Regulatory Strategy, Submissions, Compliance, and Outsourcing | Internal | Passing Juice |
| Market Access Strategy and Delivery | Internal | Passing Juice |
| Clinical Development Technology Optimization | Internal | Passing Juice |
| Clinical Trial Supply & Logistics | Internal | Passing Juice |
| Integrated evidence generation planning | Internal | Passing Juice |
| Medical Communications | Internal | Passing Juice |
| Drug Safety and Pharmacovigilance | Internal | Passing Juice |
| Global Regulatory Submissions and Outsourcing | Internal | Passing Juice |
| Real World Evidence | Internal | Passing Juice |
| Compliance and Risk Management | Internal | Passing Juice |
| Market Access Strategy and Delivery | Internal | Passing Juice |
| Integrated evidence generation planning | Internal | Passing Juice |
| Medical Communications | Internal | Passing Juice |
| Drug Safety and Pharmacovigilance | Internal | Passing Juice |
| Health economics modelling and simulation | Internal | Passing Juice |
| Real-World Evidence, Market Access Strategy and Planning | Internal | Passing Juice |
| Regulatory Compliance | Internal | Passing Juice |
| Lifecycle Optimization | Internal | Passing Juice |
| Integrated evidence generation planning | Internal | Passing Juice |
| Medical Communications | Internal | Passing Juice |
| Gain an advantage through FSP | Internal | Passing Juice |
| Leveraging AI in clinical development | Internal | Passing Juice |
| Medical affairs for clinical trials | Internal | Passing Juice |
| Biotech | Internal | Passing Juice |
| Listen Now | Internal | Passing Juice |
| Therapeutic Expertise | Internal | Passing Juice |
| Neuroscience | Internal | Passing Juice |
| General medicine | Internal | Passing Juice |
| Infectious disease and vaccines | Internal | Passing Juice |
| Immunology | Internal | Passing Juice |
| Oncology | Internal | Passing Juice |
| Hematology | Internal | Passing Juice |
| Cell and gene therapies | Internal | Passing Juice |
| Pediatrics | Internal | Passing Juice |
| Rare diseases | Internal | Passing Juice |
| Overview | Internal | Passing Juice |
| Cell and gene therapy | Internal | Passing Juice |
| Gastroenterology CRO | Internal | Passing Juice |
| Respiratory CRO | Internal | Passing Juice |
| Endocrine & Metabolic CRO | Internal | Passing Juice |
| Cardiovascular CRO | Internal | Passing Juice |
| Women's health CRO | Internal | Passing Juice |
| Critical Care | Internal | Passing Juice |
| Hepatitis B | Internal | Passing Juice |
| Novel treatments in infectious disease | Internal | Passing Juice |
| Ophthalmology CRO | Internal | Passing Juice |
| Dermatology CRO | Internal | Passing Juice |
| Allergy CRO | Internal | Passing Juice |
| Bladder cancer CRO | Internal | Passing Juice |
| Breast cancer CRO | Internal | Passing Juice |
| Gynecologic cancer CRO | Internal | Passing Juice |
| Head and neck cancer CRO | Internal | Passing Juice |
| Lung cancer CRO | Internal | Passing Juice |
| Phase I and rare tumors | Internal | Passing Juice |
| Prostate cancer CRO | Internal | Passing Juice |
| Neurology | Internal | Passing Juice |
| Psychiatry | Internal | Passing Juice |
| Pediatrics | Internal | Passing Juice |
| Rare Diseases | Internal | Passing Juice |
| Lymphoma CRO | Internal | Passing Juice |
| Acute myelogenous leukemia (AML) CRO | Internal | Passing Juice |
| Myelodysplastic syndrome (MDS) CRO | Internal | Passing Juice |
| Multiple Myeloma CRO | Internal | Passing Juice |
| Learn more | Internal | Passing Juice |
| Learn more | Internal | Passing Juice |
| Insights | Internal | Passing Juice |
| New frontiers in neuroscience | Internal | Passing Juice |
| Precision oncology | Internal | Passing Juice |
| Rare disease drug development | Internal | Passing Juice |
| Cell and gene therapy development | Internal | Passing Juice |
| Patient-guided drug development | Internal | Passing Juice |
| Clinical Trialblazers Podcast | Internal | Passing Juice |
| The Regulatory Navigator | Internal | Passing Juice |
| On The Pulse | Internal | Passing Juice |
| Learn more | Internal | Passing Juice |
| Learn more | Internal | Passing Juice |
| Participate | Internal | Passing Juice |
| Healthy volunteers | Internal | Passing Juice |
| Patient volunteers | Internal | Passing Juice |
| Patient advocacy groups | Internal | Passing Juice |
| Baltimore | External | Passing Juice |
| Los Angeles | External | Passing Juice |
| London | External | Passing Juice |
| Berlin | External | Passing Juice |
| Overview | Internal | Passing Juice |
| Advisory Council | Internal | Passing Juice |
| Patient stories | Internal | Passing Juice |
| Andrea & David's Story | Internal | Passing Juice |
| Stacy's Story | Internal | Passing Juice |
| Anisha's Story | Internal | Passing Juice |
| Rob's Story | Internal | Passing Juice |
| Learn more | Internal | Passing Juice |
| Sites | Internal | Passing Juice |
| Learn more | Internal | Passing Juice |
| About | Internal | Passing Juice |
| Leadership team | Internal | Passing Juice |
| Global reach | Internal | Passing Juice |
| Our inclusion strategy | Internal | Passing Juice |
| Our ESG strategy | Internal | Passing Juice |
| Compliance, tax & privacy | Internal | Passing Juice |
| Meet us at an event | Internal | Passing Juice |
| Overview | Internal | Passing Juice |
| Board of Directors | Internal | Passing Juice |
| Our ESG strategy | Internal | Passing Juice |
| Compliance & Ethics | Internal | Passing Juice |
| Tax Strategy | Internal | Passing Juice |
| Privacy Policy | Internal | Passing Juice |
| Cookies and other web tracking | Internal | Passing Juice |
| Supplier Data Privacy Requirements | Internal | Passing Juice |
| Terms of Use | Internal | Passing Juice |
| French Gender Pay Data | Internal | Passing Juice |
| UK Gender Pay Data | Internal | Passing Juice |
| UK Modern Slavery Act Statement | Internal | Passing Juice |
| Ireland Gender Pay Data | Internal | Passing Juice |
| Supplier Inclusion Policy | Internal | Passing Juice |
| Newsroom | Internal | Passing Juice |
| Academy | External | Passing Juice |
| Careers | Internal | Passing Juice |
| 中国 (China) | Internal | Passing Juice |
| 日本 (Japan) | Internal | Passing Juice |
| Contact Us | Internal | Passing Juice |
| Oncology | Internal | Passing Juice |
| Immunology | Internal | Passing Juice |
| Cell & Gene Therapy | Internal | Passing Juice |
| Endocrine & Metabolic | Internal | Passing Juice |
| See neuroscience capabilities | Internal | Passing Juice |
| Explore neuroscience careers | Internal | Passing Juice |
| biopharmaceutical leaders and sites | Internal | Passing Juice |
| Contact us | Internal | Passing Juice |
| My Communication Preferences | Internal | Passing Juice |
| Invoicing | Internal | Passing Juice |
| PO Terms and Conditions | Internal | Passing Juice |
SEO Keywords
Keywords Cloud
development more strategy patient cro trials medical clinical access overview
Keywords Consistency
| Keyword | Content | Title | Keywords | Description | Headings |
|---|---|---|---|---|---|
| clinical | 55 |  |
|
|
 |
| cro | 50 | |
|
|
|
| overview | 44 | |
|
|
|
| development | 36 | |
|
|
|
| strategy | 30 | |
|
|
|
Usability
Url
Domain : parexel.com
Length : 11
Favicon
Great, your website has a favicon.
Printability
We could not find a Print-Friendly CSS.
Language
Good. Your declared language is en.
Dublin Core
This page does not take advantage of Dublin Core.
Document
Doctype
HTML 5
Encoding
Perfect. Your declared charset is UTF-8.
W3C Validity
Errors : 0
Warnings : 0
Email Privacy
Great no email address has been found in plain text!
Deprecated HTML
Great! We haven't found deprecated HTML tags in your HTML.
Speed Tips
|
Excellent, your website doesn't use nested tables. |
|
Too bad, your website is using inline styles. |
|
Too bad, your website has too many CSS files (more than 4). |
|
Too bad, your website has too many JS files (more than 6). |
|
Perfect, your website takes advantage of gzip. |
Mobile
Mobile Optimization
|
Apple Icon |
|
Meta Viewport Tag |
|
Flash content |
Optimization
XML Sitemap
Great, your website has an XML sitemap.
| https://www.parexel.com/sitemap.xml |
Robots.txt
https://parexel.com/robots.txt
Great, your website has a robots.txt file.
Analytics
Missing
We didn't detect an analytics tool installed on this website.
Web analytics let you measure visitor activity on your website. You should have at least one analytics tool installed, but It can also be good to install a second in order to cross-check the data.
PageSpeed Insights
Device
Categories
Free SEO Testing Tool
Free SEO Testing Tool is a free SEO tool which provides you content analysis of the website.